However, tumor cells can also exploit the oxidative stress-ERS interplay to develop resistance—for example, by activating the ER chaperone protein GRP78 to repair misfolded proteins while enhancing the antioxidant defense system to reduce ROS levels and diminish therapeutic efficacy [86]. The gene discussed is HSPA5; the disease is neoplasm.